Medical Examiner Toxicology Data Collection

Medical Examiner-Toxicology Data Collection Items.docx

The National Forensic Laboratory Information System Collection of Analysis Data

Medical Examiner Toxicology Data Collection

OMB: 1117-0034

Document [docx]
Download: docx | pdf

Medical Examiner/Toxicology Data Collection Items

Draft



Definition

In the NFLIS ME/C data collection, a drug-involved death case is one in which the medical examiner or coroner requests toxicology analyses as a part of the death investigation and identification of a drug is confirmed. Thus, the primary data of interest is: identifying drugs present at time of death, as well as drugs identified as the cause of death or a contributing cause of death as determined by the medical examiner or corner.

Medical Examiner and Coroner Office Core Data Items

Primary data collection items (required core data set)

  • Case ID/Unique Identifier

  • Date of death

  • Date of death record

  • Examination completion date: this is the completion date of full autopsy, partial autopsy, or external exam

  • Type of examination: full autopsy, partial autopsy, external exam

  • Cause of death: include primary cause of death and contributing factors

  • Manner of death: suicide, accident, homicide, natural, undetermined

  • Location of death (county, city, and ZIP code)

  • Age of Decedent

  • Sex of Decedent

  • Race/Ethnicity of Decedent

  • Submitting agency

Secondary data collection items (data elements as available)

  • Case history

    1. History of drug use, types of drugs reported in the history of use

  • Known legitimate drug prescriptions of deceased

  • Type of toxicology analysis requested (general screen, confirmation, synthetic cannabinoid panel etc.)



Toxicology Laboratory Data Items

Primary data collection items (required core data set)

  • Case ID/Unique Identifier: if different from ME/C case ID/unique identifier

  • Requesting agency name

  • Date of analysis

  • Drug(s) identified: this should include a list of individual drugs (alprazolam) and metabolites (alpha-hydroxy alprazolam), that have been confirmed in the body of the deceased even if that drug is not implicated in death.

  • Identify whether samples were submitted to a reference laboratory for additional testing.

Secondary data collection items (data elements as available)

  • If available provide confirmation result (concentration with units (e.g., concentrations established in ng/mL)).

  • Identify matrices (i.e., peripheral blood, cardiac blood) along with the above confirmation data.



2


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorSmiley-McDonald, Hope
File Modified0000-00-00
File Created2021-11-16

© 2024 OMB.report | Privacy Policy